Toshiba Medical Systems Corporation completed the acquisition of remaining 70% stake in TI Medical Systems Co., Ltd. from Infinitt Healthcare Co., Ltd. for KRW 10 billion.
April 03, 2013 at 12:00 am EDT
Share
Toshiba Medical Systems Corporation agreed to acquire remaining 70% stake in TI Medical Systems Co., Ltd. from Infinitt Healthcare Co., Ltd. (KOSE:A071200) for KRW 9.8 billion on February 28, 2013. Toshiba Medical Systems will acquire 0.28 million shares of TI Medical Systems. The Board of Directors resolved the transaction on February 28, 2013. The transaction is subject to approval from fair trade regulators in both South Korea and Japan. The transaction is expected to close on May 31, 2013.
Toshiba Medical Systems Corporation completed the acquisition of remaining 70% stake in TI Medical Systems Co., Ltd. from Infinitt Healthcare Co., Ltd. (KOSE:A071200) for KRW 10 billion on April 3, 2013.
INFINITT Healthcare Co., Ltd. is a Korea-based company engaged in the research, development and distribution of medical imaging and information solutions and services. The Company provides picture archiving and communication systems (PACSs), including radiology PACSs, dental PACSs and cardiology PACSs, and research and information systems (RISs), three dimensional (3D) visualization solutions, clinical information systems (CISs) and others. It also provides cloud PACS services, tele-radiology services, maintenance services, outsourcing services, solution upgrade services, solution replacement services, technical support services and others. The Company distributes its products within domestic market and to overseas markets, including America and Europe. On April 3, 2013, the Company sold its entire 70% stake in TI Medical Systems. Co., Ltd, engaged in the development, manufacturing and sales of electrical medicine machines.
Toshiba Medical Systems Corporation completed the acquisition of remaining 70% stake in TI Medical Systems Co., Ltd. from Infinitt Healthcare Co., Ltd. for KRW 10 billion.
INFINITT HEALTHCARE CO., LTD. 
